Drug intelligence / Profile preview

ibuprofen + codeine

Development stage
Unknown
Lead developer
Reckitt
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Ibuprofen + codeine is a fixed-dose combination analgesic containing the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen and the opioid analgesic codeine. Ibuprofen acts primarily by inhibiting cyclooxygenase (COX-1 and COX-2), thereby reducing prostaglandin synthesis, which leads to decreased inflammation, pain, and fever. Codeine is a weak opioid that exerts its effect mainly through partial metabolic conversion to morphine; it binds to mu-opioid receptors in the central nervous system, altering pain perception and response. The combination provides additive or synergistic pain relief for acute moderate pain when other non-opioid options are insufficient[3][5][10]. It is used for short-term management of mild to moderate pain such as postoperative or dental pain[3][5]. The efficacy of this combination has been demonstrated in clinical studies, though some evidence suggests it may not always be superior to ibuprofen alone[1][7].

Brand names
Nurofen Plus
Other names
ibuprofen/codeine phosphateibuprofen and codeine
02

Targets

MOR (Mu opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ibuprofen + codeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + codeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call